229 related articles for article (PubMed ID: 36601438)
1. [The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas].
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
Rev Panam Salud Publica; 2022; 46():e112. PubMed ID: 36601438
[TBL] [Abstract][Full Text] [Related]
2. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
Rev Esp Cardiol (Engl Ed); 2021 Sep; 74(9):790-799. PubMed ID: 34446261
[TBL] [Abstract][Full Text] [Related]
3. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
Int J Surg; 2021 Apr; 88():105906. PubMed ID: 33789826
[TBL] [Abstract][Full Text] [Related]
4. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
J Clin Epidemiol; 2021 Jun; 134():178-189. PubMed ID: 33789819
[TBL] [Abstract][Full Text] [Related]
5. Correction in the article «Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas», Rev Esp Cardiol. 2021;74:790-799.
Rev Esp Cardiol (Engl Ed); 2022 Feb; 75(2):192. PubMed ID: 34955441
[No Abstract] [Full Text] [Related]
6. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension.
O'Dea RE; Lagisz M; Jennions MD; Koricheva J; Noble DWA; Parker TH; Gurevitch J; Page MJ; Stewart G; Moher D; Nakagawa S
Biol Rev Camb Philos Soc; 2021 Oct; 96(5):1695-1722. PubMed ID: 33960637
[TBL] [Abstract][Full Text] [Related]
7. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
[TBL] [Abstract][Full Text] [Related]
8. Exploring reporting quality of systematic reviews and Meta-analyses on nursing interventions in patients with Alzheimer's disease before and after PRISMA introduction.
Sun X; Zhou X; Yu Y; Liu H
BMC Med Res Methodol; 2018 Nov; 18(1):154. PubMed ID: 30497417
[TBL] [Abstract][Full Text] [Related]
9. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
[TBL] [Abstract][Full Text] [Related]
10. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Moher D
J Clin Epidemiol; 2021 Jun; 134():103-112. PubMed ID: 33577987
[TBL] [Abstract][Full Text] [Related]
11. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
[TBL] [Abstract][Full Text] [Related]
12. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
[TBL] [Abstract][Full Text] [Related]
13. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
[TBL] [Abstract][Full Text] [Related]
14. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
PLoS Med; 2009 Jul; 6(7):e1000100. PubMed ID: 19621070
[TBL] [Abstract][Full Text] [Related]
15. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
Int J Equity Health; 2015 Oct; 14():92. PubMed ID: 26450828
[TBL] [Abstract][Full Text] [Related]
16. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
[TBL] [Abstract][Full Text] [Related]
17. Do reporting guidelines have an impact? Empirical assessment of changes in reporting before and after the PRISMA extension statement for network meta-analysis.
Veroniki AA; Tsokani S; Zevgiti S; Pagkalidou I; Kontouli KM; Ambarcioglu P; Pandis N; Lunny C; Nikolakopoulou A; Papakonstantinou T; Chaimani A; Straus SE; Hutton B; Tricco AC; Mavridis D; Salanti G
Syst Rev; 2021 Sep; 10(1):246. PubMed ID: 34507621
[TBL] [Abstract][Full Text] [Related]
18. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review.
Page MJ; Moher D
Syst Rev; 2017 Dec; 6(1):263. PubMed ID: 29258593
[TBL] [Abstract][Full Text] [Related]
19. Quality Reporting of Systematic Review and Meta-Analysis According to PRISMA 2020 Guidelines: Results from Recently Published Papers in the
Park HY; Suh CH; Woo S; Kim PH; Kim KW
Korean J Radiol; 2022 Mar; 23(3):355-369. PubMed ID: 35213097
[TBL] [Abstract][Full Text] [Related]
20. Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist.
Wang X; Chen Y; Liu Y; Yao L; Estill J; Bian Z; Wu T; Shang H; Lee MS; Wei D; Tian J; Ma B; Wang Y; Tian G; Yang K
BMC Complement Altern Med; 2019 Aug; 19(1):208. PubMed ID: 31405367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
